Resumo:
En
|
Texto:
En
|
PDF:
En
ABSTRACT This study investigated the effect of resveratrol on the immune and inflammatory responses and the mRNA levels of splenic toll-like receptor (TLR)-4 signaling pathway-related genes of broilers under heat stress (HS). One hundred and sixty-two birds were allocated to three groups, each with 6 replicates, for 21 continuous days. The three treatments were as follows: the control group (22 ± 1 °C), the HS (33 ± 1 °C for 10 h d-1 and 22 ± 1 °C for the remaining time) group and the HS + resveratrol (400 mg kg-1) group. At the end of the trial, one bird per replicate close to the average body weight (BW) was selected, exsanguinated, and slaughtered. Compared with the control group, the HS treatment decreased (p<0.05) final BW, average daily gain (ADG), average daily feed intake (ADFI), relative weight of bursa of Fabricius and spleen, serum immunoglobulin (Ig) Y, IgA and interleukin (IL)-10 contents, and splenic IL-10 mRNA level, while it increased (p<0.05) feed/gain, mRNA levels of splenic tumor necrosis factor-α (TNF-α), TLR-4, nuclear factor-kappa-B (NF-κB), IL-1β, and IL-6. Compared to the HS group, the HS+resveratrol group exhibited increased (p<0.05) final BW, ADG, relative weight of bursa of Fabricius and spleen, serum IgY, IgA and IL-10 contents, and splenic IL-10 mRNA level, while it exhibited lower (p<0.05) TNF-α, IL-1β and IL-6 contents in serum, and splenic TLR4, TNF-α, IL-1β, and NF-κB mRNA levels. In conclusion, resveratrol prevented a HS-impairment of the immune function of broilers by blocking the abnormal activation of the TLR4 signaling pathway. tolllike toll like TLR 4 (TLR)- pathwayrelated pathway related HS. . (HS) sixtytwo sixty two groups replicates 2 days follows (2 °C, C , °C) 33 (3 d1 d d- time 400 (40 kg1 kg kg-1 trial BW (BW selected exsanguinated slaughtered p<0.05 p005 p 0 05 (p<0.05 ADG (ADG) ADFI, ADFI (ADFI) spleen Ig (Ig Y IL10 IL (IL)-1 IL-1 level feedgain feed/gain factorα factor α TNFα, TNFα TNF (TNF-α) 4, TLR-4 factorkappaB kappa B NFκB, NFκB NF κB (NF-κB) IL1β, IL1β ILβ 1β, 1β β IL6. IL6 6. HSresveratrol IgY α, TNF-α IL- conclusion HSimpairment impairment (TLR) (HS ( 3 40 (4 kg- p<0.0 p00 (p<0.0 (ADG (ADFI IL1 (IL)- (TNF-α TLR- (NF-κB (TLR p<0. p0 (p<0. (IL) p<0 (p<0 (IL p< (p< (p